文献速递免疫规划传染病防控与疫情报告

美国十城市性活跃非裔女性九价HPV疫苗型别纵向评估

Longitudinal assessment of nonavalent vaccine HPV types in a sample of sexually active African American women from ten U.S. Cities.
PubMed 文献 · Vaccine · 2021-07-20

本研究为BRAVO试验子研究,对80名18–25岁性活跃非裔女性进行四个月随访,用定量PCR检测阴道拭子中九价疫苗可预防HPV型别。约30%女性在三次随访均检出至少一种疫苗型别,最常见为52、58、16、18型;任意疫苗型别和高危型别患病率分别为63.8%和58.8%。作者认为九价HPV疫苗可能比既往认为更有益。

要点

  • 四个月内约30%女性持续检出至少一种九价疫苗HPV型别。
  • 最常见疫苗型别为52、58、16、18型。
  • 任意疫苗型别患病率63.8%,高危型别58.8%。

核心结论

  • 九价HPV疫苗可能比既往认为更有益,因数据收集时该疫苗尚不可用。

研究设计与样本

  • BRAVO随机开放标签试验子研究,纳入80名18–25岁性活跃非裔女性,每2个月随访共12个月。
  • 检测前三次访视储存阴道拭子中九种疫苗可预防HPV型别,用定量PCR。

主要发现

  • 平均年龄21.5岁(SD±2.11),60%曾怀孕,71%报告既往一年≥2个性伴。
  • 约30%在四个月三次时间点均检出至少一种九价疫苗HPV型别,15%在任意三次中两次检出,19%一次检出,36%全部阴性。
  • 最常见疫苗型别为52、58、16、18型;任意疫苗型别患病率63.8%,高危型别58.8%。

临床怎么用

  • 支持对至26岁未接种者推荐HPV疫苗接种,尤其性活跃年轻女性。

局限性

  • 子研究样本量80人,全部为非裔女性,数据收集时九价疫苗尚不可用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic infection with high-risk human papillomavirus is a necessary cause for cervical carcinogenesis. This study examined prevalence of nonavalent vaccine preventable HPV types over four months among sexually active women in the United States. METHODS: This sub-study obtained meta-data for 80 of the 1,365 women (18-25 years), enrolled in the BRAVO study, a randomized, open-label trial of home screening and treatment of asymptomatic bacterial vaginosis at high-risk for sexually transmitted infections conducted between 2008 and 2013. Participants were randomized to treatment or standard-of-care, and followed every 2-months for 12 months. Stored vaginal swabs from the first three visits were tested for the nine vaccine preventable HPV types using quantitative PCR. Prevalence and associated 95% confidence intervals for the HPV types were assessed using R (version 3.6.1). RESULTS: The average age of the participants was 21.5 (SD ± 2.11) years, with 60% having ever been pregnant and all were African-American. Majority (71%) reported ≥ two sex partners in the prior year with 89% having unprotected vaginal sex and 45% having a new sex partner in the prior year. About 30% had ≥ one of the nine nonavalent vaccine HPV types at all three time points over a period of four months, 15% at two of any three visits, 19% at one of the three visits and 36% were negative for all nine vaccine HPV types at all time points. The most frequently detected HPV vaccine types were 52, 58, 16, and 18. The prevalence of any vaccine HPV types, and high-risk HPV types was 63.8% and 58.8%, respectively. CONCLUSIONS: Our findings suggest that HPV vaccination which is currently recommended for all unvaccinated persons through age 26 years, is likely to be more beneficial than previously thought as nonavalent HPV vaccine was not available during the time these data were collected.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Madhivanan P, Krupp K, Coudray M, et al. Longitudinal assessment of nonavalent vaccine HPV types in a sample of sexually active African American women from ten U.S. Cities. Vaccine. 2021. PMID: 34294478. doi:10.1016/j.vaccine.2021.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。